Achieve Life Sciences, Inc. (ACHV) Earnings History
Net Loss32 years of earnings data (1994–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Achieve Life Sciences, Inc. (ACHV) Earnings Overview
As of June 28, 2026, Achieve Life Sciences, Inc. (ACHV) reported trailing twelve-month net income of -$52M, reflecting -0.8% year-over-year growth. The company earned $-0.97 per diluted share over the past four quarters.
Looking at the long-term picture, ACHV's historical earnings data spans multiple years. The company achieved its highest annual net income of $5M in fiscal 2009.
Achieve Life Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PTGX (-$115M net income, -282.8% margin), ATAI (-$663M net income, -16142.0% margin), GFAI (-$13M net income, -18.9% margin), ACHV has comparable earnings metrics. Compare ACHV vs PTGX →
ACHV Earnings vs Peers
Earnings metrics vs comparable public companies
ACHV Historical Earnings Data (1994–2025)
32 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$55M | -37.2% | -$55M | $-1.25 | - | - |
| 2024 | -$40M | -33.6% | -$39M | $-1.24 | - | - |
| 2023 | -$30M | +29.6% | -$27M | $-1.50 | - | - |
| 2022 | -$42M | -27.7% | -$41M | $-3.95 | - | - |
| 2021 | -$33M | -126.1% | -$33M | $-4.05 | - | - |
| 2020 | -$15M | +10.6% | -$15M | $-5.39 | - | - |
| 2019 | -$16M | -29.2% | -$17M | $-39.15 | - | - |
| 2018 | -$13M | -19.9% | -$13M | $-72.29 | - | - |
| 2017 | -$11M | +47.4% | -$7M | $-441.47 | - | - |
| 2016 | -$20M | -19.8% | -$21M | $-1474.98 | -397.6% | -418.6% |
| 2015 | -$17M | +36.0% | -$19M | $-1413.63 | -92.5% | -103.3% |
| 2014 | -$26M | +17.6% | -$29M | $-3189.89 | -96.8% | -108.7% |
| 2013 | -$32M | -51.0% | -$35M | $-4772.10 | -106.6% | -118.2% |
| 2012 | -$21M | -43.8% | -$26M | $-3432.80 | -105.0% | -129.3% |
| 2011 | -$15M | -16.6% | -$22M | $-3318.18 | -267.0% | -405.5% |
| 2010 | -$13M | -329.8% | -$15M | $-3938.65 | -92.4% | -108.3% |
| 2009 | $5M | +230.3% | -$2M | $1905.36 | 21.4% | -9.7% |
| 2008 | -$4M | +67.8% | -$6M | $-1677.57 | -20.9% | -31.1% |
| 2007 | -$13M | +44.5% | -$15M | $-13971.30 | -64.9% | -75.7% |
| 2006 | -$24M | -11.6% | -$26M | $-25323.97 | -105.2% | -117.4% |
| 2005 | -$21M | -29.3% | -$22M | $-27363.19 | -255.6% | -264.2% |
| 2004 | -$16M | -55.8% | -$17M | $-30260.84 | -6.2% | -6.3% |
| 2003 | -$10M | +10.0% | -$11M | $-23106.18 | -41868.4% | -42552.6% |
| 2002 | -$12M | -2246.1% | -$12M | $-33726.96 | -46543.2% | -48696.4% |
| 2001 | $542,177 | +125.2% | $216,347 | $1844.14 | 6.2% | 2.5% |
| 2000 | -$2M | -636.9% | -$7M | $-8873.71 | -525.8% | -1771.0% |
| 1999 | $400,000 | +103.6% | $900,000 | $1914.85 | 3.3% | 7.4% |
| 1998 | -$11M | -1220.0% | -$12M | $-51612.90 | -219.6% | -233.3% |
| 1997 | $1M | -41.2% | $100,000 | $4608.29 | 5.3% | 0.5% |
| 1996 | $2M | +128.8% | $2M | $7906.98 | 10.2% | 9.6% |
| 1995 | -$6M | +33.7% | -$5M | $-27699.53 | -131.1% | -111.1% |
| 1994 | -$9M | - | -$8M | $-41784.04 | -809.1% | -745.5% |
Download Data
Export ACHV earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
32+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ACHV — Frequently Asked Questions
Quick answers to the most common questions about buying ACHV stock.
What is ACHV earnings per share (EPS)?
ACHV trailing twelve-month (TTM) diluted EPS is $-0.97, reflecting -0.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1994 to 2025 is available in the table on this page.
What is Achieve Life Sciences, Inc.'s net income?
Achieve Life Sciences, Inc. (ACHV) trailing twelve-month net income is $-52M as of 2025. Earnings declined -0.8% year-over-year.
Is ACHV profitable?
ACHV is not currently profitable on a TTM basis, reporting a net loss of $-52M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ACHV's earnings growth rate?
ACHV compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1994 to 2025.
What are ACHV's profit margins?
Achieve Life Sciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -257.7%.
Is ACHV growing earnings?
ACHV earnings growth is slowing. Current YoY EPS growth of -0.8% trails the 5-year CAGR of N/A. TTM net income is $-52M.
What was ACHV's best earnings year?
Achieve Life Sciences, Inc.'s highest annual net income on record is $5M, achieved in fiscal year 2009. Earnings history on this page spans 1994 to 2025 and includes all annual and quarterly figures.
What were ACHV's earnings last quarter?
ACHV's most recent reported quarter was Q1 2026. Net income was $-10M with diluted EPS of $-0.19. For a full breakdown of all quarters, see the quarterly earnings table on this page.